all report title image
  • Published On : May 2020
  • Code : CMI3861
  • Industry : Medical Devices
  • Pages : 183
  • Formats :
Ingographics Image

Electrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has property to activate electrical impulse and transmit signal to electrodes of device, which causes depolarization and in turn reduces pain and improves muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.

Restraints of the Global Neuromodulation Devices Market

Side effects and risks associated with the use of neuromodulation devices are expected to hinder growth of the global neuromodulation devices market.

Key features of the study:

  • This report provides in-depth analysis of the global neuromodulation devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global neuromodulation devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Axonics Modulation Technologies, Inc., ShiraTronics, Inc., Bioness, Inc., LivaNova, Neuronetics, Inc., Medtronic plc, St. Jude Medical, Boston Scientific Corporation, Cyberonics, Nevro, Integer Holdings Corporation, and Uroplasty
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Neuromodulation Devices Market, By Device Type:
    • Spinal Cord Stimulation Devices
    • Deep Brain Stimulation Devices
    • Sacral Nerve Stimulation Devices
    • Vagus Nerve Stimulation Devices
    • Gastric Electric Stimulation Devices
  • Global Neuromodulation Devices Market, By Application:
    • Pain Management
    • Neurological and Movement Disorder Management
    • Musculoskeletal Disorder Management
    • Metabolism & GIT Management
    • Incontinence Management
    • Others
  • Global Neuromodulation Devices Market, By End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Centers
    • Others
  • Global Neuromodulation Devices Market, By Geography:
    • North America
      • By Device Type
        • Spinal Cord Stimulation Devices
        • Deep Brain Stimulation Devices
        • Sacral Nerve Stimulation Devices
        • Vagus Nerve Stimulation Devices
        • Gastric Electric Stimulation Devices
      • By Application:
        • Pain Management
        • Neurological and Movement Disorder Management
        • Musculoskeletal Disorder Management
        • Metabolism & GIT Management
        • Incontinence Management
        • Others
      • By End User
        • Hospitals
        • Specialty Clinics
        • Ambulatory Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Device Type
        • Spinal Cord Stimulation Devices
        • Deep Brain Stimulation Devices
        • Sacral Nerve Stimulation Devices
        • Vagus Nerve Stimulation Devices
        • Gastric Electric Stimulation Devices
      • By Application:
        • Pain Management
        • Neurological and Movement Disorder Management
        • Musculoskeletal Disorder Management
        • Metabolism & GIT Management
        • Incontinence Management
        • Others
      • By End User
        • Hospitals
        • Specialty Clinics
        • Ambulatory Centers
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Device Type
        • Spinal Cord Stimulation Devices
        • Deep Brain Stimulation Devices
        • Sacral Nerve Stimulation Devices
        • Vagus Nerve Stimulation Devices
        • Gastric Electric Stimulation Devices
      • By Application:
        • Pain Management
        • Neurological and Movement Disorder Management
        • Musculoskeletal Disorder Management
        • Metabolism & GIT Management
        • Incontinence Management
        • Others
      • By End User
        • Hospitals
        • Specialty Clinics
        • Ambulatory Centers
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Device Type
        • Spinal Cord Stimulation Devices
        • Deep Brain Stimulation Devices
        • Sacral Nerve Stimulation Devices
        • Vagus Nerve Stimulation Devices
        • Gastric Electric Stimulation Devices
      • By Application:
        • Pain Management
        • Neurological and Movement Disorder Management
        • Musculoskeletal Disorder Management
        • Metabolism & GIT Management
        • Incontinence Management
        • Others
      • By End User
        • Hospitals
        • Specialty Clinics
        • Ambulatory Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Device Type
        • Spinal Cord Stimulation Devices
        • Deep Brain Stimulation Devices
        • Sacral Nerve Stimulation Devices
        • Vagus Nerve Stimulation Devices
        • Gastric Electric Stimulation Devices
      • By Application:
        • Pain Management
        • Neurological and Movement Disorder Management
        • Musculoskeletal Disorder Management
        • Metabolism & GIT Management
        • Incontinence Management
        • Others
      • By End User
        • Hospitals
        • Specialty Clinics
        • Ambulatory Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Device Type
        • Spinal Cord Stimulation Devices
        • Deep Brain Stimulation Devices
        • Sacral Nerve Stimulation Devices
        • Vagus Nerve Stimulation Devices
        • Gastric Electric Stimulation Devices
      • By Application:
        • Pain Management
        • Neurological and Movement Disorder Management
        • Musculoskeletal Disorder Management
        • Metabolism & GIT Management
        • Incontinence Management
        • Others
      • By End User
        • Hospitals
        • Specialty Clinics
        • Ambulatory Centers
        • Others
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Axonics Modulation Technologies, Inc.* 
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • ShiraTronics, Inc.
    • Bioness, Inc.
    • LivaNova
    • Neuronetics, Inc.
    • Medtronic plc
    • Jude Medical
    • Boston Scientific Corporation
    • Cyberonics
    • Nevro
    • Integer Holdings Corporation
    • Uroplasty

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Device Type
      • Market Snippet, By Application
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario
  4. Global Neuromodulation Devices Market, By Device Type, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Spinal Cord Stimulation Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Deep Brain Stimulation Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Sacral Nerve Stimulation Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Vagus Nerve Stimulation Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Gastric Electric Stimulation Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Neuromodulation Devices Market, By Application, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Pain Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Neurological and Movement Disorder Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Musculoskeletal Disorder Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Metabolism & GIT Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Incontinence Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  6. Global Neuromodulation Devices Market, By End User, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Ambulatory Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  7. Global Neuromodulation Devices Market, By Regions, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Axonics Modulation Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • ShiraTronics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bioness, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • LivaNova
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Neuronetics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Medtronic plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • St. Jude Medical
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cyberonics
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Nevro
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Integer Holdings Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Uroplasty
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 37 market data tables and 25 figures on “Neuromodulation Devices Market – Global forecast to 2027.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo